A study has suggested that the current strategies aimed at changing perceptions towards measles, mumps and rubella vaccinations only serve to reinforce these false beliefs.
Browsing: Clinical > Outcomes Research
In this interview, we discuss public health and music playlists with Natasha Crowcroft, Chief of Applied Immunization Research and Evaluation at Public Health Ontario and Professor in Laboratory Medicine and Pathobiology and the Dalla Lana School of Public Health at the University of Toronto.
A new analysis has suggested that the notion of ‘completing the course’ when taking antibiotics is not evidence-based and should be dropped as it may actually increase the risk of antibiotic resistance.
In this interview with Patrick Harris, from the University of Queensland, we discuss his role in setting up and co-ordinating the MERINO trial, and his research on the use of genomics in clinical microbiology.
It may be possible to interrupt the transmission of soil-transmitted helminths, which affect nearly 2 billion individuals globally. Here, the authors give an overview of the DeWorm3 project, which aims to test the feasibility of interrupting soil-transmitted helminth transmission.
In this interview, Roy Anderson, Director for the London Centre for Neglected Tropical Disease Research speaks about the work undertaken by the Centre and gives his thoughts on the wider NTD field.
Martin Olivier, discusses how the nanobiome of vectors may impact the infectious processes of disease, highlighting his work on exosomes in sandflies and leishmaniasis.
The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries. In this research article, the authors carry out a multi-country case study investigating the the adoption and use of HPV vaccines.
Researchers have quantified the burden of stigmatization and discrimination on lymphatic filariasis patients, discovering individuals are up to four times more likely to suffer depression than average.
Recent studies suggest that the risk of a heart attack could be increased 17-fold during the 7 days after a respiratory infection.